Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Medtronic & Abbott share new TAVR data | Addressing health disparities at the local level | A risky artificial sweetener
Wednesday, March 1, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Medtronic, Abbott share late-breaking TAVR data at CRT 2023

Both vendors used the four-day conference as an opportunity to provide key updates about their TAVR valves.

READ MORE >
Medtronic CoreValve Evolute
Share on Twitter Share on Facebook Share on Linkedin

Medtronic, Abbott share late-breaking TAVR data at CRT 2023

Share on Twitter Share on Facebook Share on Linkedin
Medtronic CoreValve Evolute
Both vendors used the four-day conference as an opportunity to provide key updates about their TAVR valves.
READ MORE >

How cardiologists can address health disparities in their communities

Incoming 2023-2024 American College of Cardiology president Hadley Wilson, MD, shared insights on how to create health equity through grassroots community outreach programs.

READ MORE >
Incoming 2023-2024 American College of Cardiology (ACC) president Hadley Wilson, MD, shares insights on how to create health equity through both ACC programs and hospital grassroots community outreach programs. He outlines four programs his heart hospital is piloting in its community in Charlotte, North Carolina.
Share on Twitter Share on Facebook Share on Linkedin

How cardiologists can address health disparities in their communities

Share on Twitter Share on Facebook Share on Linkedin
Incoming 2023-2024 American College of Cardiology (ACC) president Hadley Wilson, MD, shares insights on how to create health equity through both ACC programs and hospital grassroots community outreach programs. He outlines four programs his heart hospital is piloting in its community in Charlotte, North Carolina.
Incoming 2023-2024 American College of Cardiology president Hadley Wilson, MD, shared insights on how to create health equity through grassroots community outreach programs.
READ MORE >

Popular artificial sweetener associated with greater risk of heart attack, stroke

The new study, led by a team of Cleveland Clinic specialists, was published in Nature Medicine. 

READ MORE >
The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.
Share on Twitter Share on Facebook Share on Linkedin

Popular artificial sweetener associated with greater risk of heart attack, stroke

Share on Twitter Share on Facebook Share on Linkedin
The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.
The new study, led by a team of Cleveland Clinic specialists, was published in Nature Medicine. 
READ MORE >

Featured Articles

New direct wire pacing device shows potential during PCI and TAVR, first-in-human study finds

Early evidence suggests the Electroducer Sleeve is safe and effective among patients presenting for certain interventional procedures. 

READ MORE >
ElectroDucer Sleeve PCI TAVR EuroIntervention
Share on Twitter Share on Facebook Share on Linkedin

New direct wire pacing device shows potential during PCI and TAVR, first-in-human study finds

Share on Twitter Share on Facebook Share on Linkedin
ElectroDucer Sleeve PCI TAVR EuroIntervention
Early evidence suggests the Electroducer Sleeve is safe and effective among patients presenting for certain interventional procedures. 
READ MORE >

Heart attack deaths down in US: ‘We’re making progress in the right direction’

The study, to be presented March 5 at ACC.23/WCC in New Orleans, examined outcomes data from 1999 to 2020. 

READ MORE >
New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.
Share on Twitter Share on Facebook Share on Linkedin

Heart attack deaths down in US: ‘We’re making progress in the right direction’

Share on Twitter Share on Facebook Share on Linkedin
New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.
The study, to be presented March 5 at ACC.23/WCC in New Orleans, examined outcomes data from 1999 to 2020. 
READ MORE >

FDA warns that early deterioration is possible with Abbott’s Trifecta heart valves

Early SVD has been reported in these devices, particularly three to four years after implantation. According to the FDA, this has resulted in surgical replacement procedures and transcatheter valve-in-valve interventions. In some cases, the patient died.

READ MORE >
Abbott and the U.S. Food and Drug Administration (FDA) are warning healthcare providers about the potential risk of early structural valve deterioration (SVD) with Abbott’s line of Trifecta bioprosthetic heart valves. This includes the original Trifecta valve and the Trifecta GT, which are both designed to treat disease, damaged or malfunctioning aortic heart valves.
Share on Twitter Share on Facebook Share on Linkedin

FDA warns that early deterioration is possible with Abbott’s Trifecta heart valves

Share on Twitter Share on Facebook Share on Linkedin
Abbott and the U.S. Food and Drug Administration (FDA) are warning healthcare providers about the potential risk of early structural valve deterioration (SVD) with Abbott’s line of Trifecta bioprosthetic heart valves. This includes the original Trifecta valve and the Trifecta GT, which are both designed to treat disease, damaged or malfunctioning aortic heart valves.
Early SVD has been reported in these devices, particularly three to four years after implantation. According to the FDA, this has resulted in surgical replacement procedures and transcatheter valve-in-valve interventions. In some cases, the patient died.
READ MORE >

In Case You Missed It

ACC urges all interventional cardiologists to use intravascular imaging during PCI

New recommendations from the American College of Cardiology detail how intravascular imaging can help clinicians before, during and after PCI procedures. 

READ MORE >
The ACC released a new guideline asking interventional cardiologists to use intravascular imaging to improve outcomes in percutaneous coronary intervention (PCI). Intravascular ultrasound (IVUS) is a catheter-based imaging technology that allows physicians to visualize blood vessels from the inside out. Image courtesy of Philips. 
Share on Twitter Share on Facebook Share on Linkedin

ACC urges all interventional cardiologists to use intravascular imaging during PCI

Share on Twitter Share on Facebook Share on Linkedin
The ACC released a new guideline asking interventional cardiologists to use intravascular imaging to improve outcomes in percutaneous coronary intervention (PCI). Intravascular ultrasound (IVUS) is a catheter-based imaging technology that allows physicians to visualize blood vessels from the inside out. Image courtesy of Philips. 
New recommendations from the American College of Cardiology detail how intravascular imaging can help clinicians before, during and after PCI procedures. 
READ MORE >

Bijoy K. Khandheria, a cardiologist known for his generosity and kindness, dies at 66

"He will be deeply missed by everyone who had the pleasure of interacting with him and learning from him," according to a loving tribute from the American Society of Echocardiography.

READ MORE >
candles funeral dead respect
Share on Twitter Share on Facebook Share on Linkedin

Bijoy K. Khandheria, a cardiologist known for his generosity and kindness, dies at 66

Share on Twitter Share on Facebook Share on Linkedin
candles funeral dead respect
"He will be deeply missed by everyone who had the pleasure of interacting with him and learning from him," according to a loving tribute from the American Society of Echocardiography.
READ MORE >

In Other News

AI competition furthers research on computer-aided detection in breast imaging

For the challenge, eight teams were tasked with developing algorithms capable of achieving high sensitivity for lesion detection on DBT exams.

READ MORE >
An example of architectural distortion in a 3D DBT mammogram, which is easier to see because the radiologist can look at the breast tissue layer-by-layer.
Share on Twitter Share on Facebook Share on Linkedin

AI competition furthers research on computer-aided detection in breast imaging

Share on Twitter Share on Facebook Share on Linkedin
An example of architectural distortion in a 3D DBT mammogram, which is easier to see because the radiologist can look at the breast tissue layer-by-layer.
For the challenge, eight teams were tasked with developing algorithms capable of achieving high sensitivity for lesion detection on DBT exams.
READ MORE >

Hospital CEO turnover is on the rise

The number of CEO changes at U.S. companies rose 12% from December 2022 to January 2023, with hospital CEOs playing a key part in that trend. 

READ MORE >
When the American College of Cardiology and American Heart Association collaborated on new valvular heart disease (VHD) guidelines in 2020, the two groups highlighted the importance of interventional treatment options such as transcatheter aortic valve replacement (TAVR). However, an estimated one-third of patients with severe aortic stenosis (AS) in the U.S. still lack a guideline-recommended treatment plan, dramatically lowering their chances of survival. Doctor at computer
Share on Twitter Share on Facebook Share on Linkedin

Hospital CEO turnover is on the rise

Share on Twitter Share on Facebook Share on Linkedin
When the American College of Cardiology and American Heart Association collaborated on new valvular heart disease (VHD) guidelines in 2020, the two groups highlighted the importance of interventional treatment options such as transcatheter aortic valve replacement (TAVR). However, an estimated one-third of patients with severe aortic stenosis (AS) in the U.S. still lack a guideline-recommended treatment plan, dramatically lowering their chances of survival. Doctor at computer
The number of CEO changes at U.S. companies rose 12% from December 2022 to January 2023, with hospital CEOs playing a key part in that trend. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme